Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2011 1
2012 2
2013 2
2014 9
2015 6
2016 7
2017 4
2018 6
2019 5
2020 5
2021 2
2022 5
2023 5
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors. Kowal-Bielecka O, et al. Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9. Ann Rheum Dis. 2017. PMID: 27941129 Free article.
[Ø. Midtvedt and colleagues reply].
Midtvedt Ø, Gran JT, Solheim H, Kirkhus E, Spetalen S. Midtvedt Ø, et al. Tidsskr Nor Laegeforen. 2014 Oct 14;134(19):1823. doi: 10.4045/tidsskr.14.1151. eCollection 2014 Oct 14. Tidsskr Nor Laegeforen. 2014. PMID: 25314975 Free article. Norwegian. No abstract available.
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort.
Elhai M, Sritharan N, Boubaya M, Balbir-Gurman A, Siegert E, Hachulla E, de Vries-Bouwstra J, Riemekasten G, Distler JHW, Rosato E, Del Galdo F, Mendoza FA, Furst DE, de la Puente C, Hoffmann-Vold AM, Gabrielli A, Distler O, Bloch-Queyrat C, Allanore Y; EUSTAR collaborators. Elhai M, et al. Lancet Rheumatol. 2022 Nov;4(11):e785-e794. doi: 10.1016/S2665-9913(22)00217-X. Lancet Rheumatol. 2022. PMID: 38265945
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial.
Fretheim H, Barua I, Bakland G, Dhainaut A, Halse AK, Carstens MN, Didriksen H, Midtvedt Ø, Lundin KEA, Aabakken L, Sarna VK, Zaré HK, Khanna D, Distler O, Midtvedt T, Bækkevold ES, Olsen IC, Domanska D, Pesonen ME, Molberg Ø, Hoffmann-Vold AM. Fretheim H, et al. Among authors: midtvedt o. Lancet Rheumatol. 2025 May;7(5):e323-e332. doi: 10.1016/S2665-9913(24)00334-5. Epub 2025 Jan 31. Lancet Rheumatol. 2025. PMID: 39900089 Clinical Trial.
Gastrointestinal symptom severity and progression in systemic sclerosis.
van Leeuwen NM, Boonstra M, Fretheim H, Brunborg C, Midtvedt Ø, Garen T, Molberg Ø, Huizinga TWJ, de Vries-Bouwstra JK, Hoffman-Vold AM. van Leeuwen NM, et al. Among authors: midtvedt o. Rheumatology (Oxford). 2022 Oct 6;61(10):4024-4034. doi: 10.1093/rheumatology/keac118. Rheumatology (Oxford). 2022. PMID: 35238377 Free PMC article.
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.
Hoffmann-Vold AM, Petelytska L, Fretheim H, Aaløkken TM, Becker MO, Jenssen Bjørkekjær H, Brunborg C, Bruni C, Clarenbach C, Diep PP, Dobrota R, Durheim MT, Elhai M, Frauenfelder T, Huang S, Jordan S, Langballe E, Midtvedt Ø, Mihai C, Mulcaire-Jones E, Pugashetti JV, Sprecher M, Oldham J, Molberg Ø, Khanna D, Distler O. Hoffmann-Vold AM, et al. Among authors: midtvedt o. Lancet Rheumatol. 2025 May 14:S2665-9913(25)00026-8. doi: 10.1016/S2665-9913(25)00026-8. Online ahead of print. Lancet Rheumatol. 2025. PMID: 40381640
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort.
Scheidegger M, Boubaya M, Garaiman A, Barua I, Becker M, Bjørkekjær HJ, Bruni C, Dobrota R, Fretheim H, Jordan S, Midtvedt O, Mihai C, Hoffmann-Vold AM, Distler O, Elhai M. Scheidegger M, et al. Among authors: midtvedt o. RMD Open. 2024 Jan 9;10(1):e003658. doi: 10.1136/rmdopen-2023-003658. RMD Open. 2024. PMID: 38199606 Free PMC article.
Serum markers of cardiac complications in a systemic sclerosis cohort.
Tennøe AH, Murbræch K, Didriksen H, Ueland T, Palchevskiy V, Weigt SS, Fretheim H, Midtvedt Ø, Garen T, Brunborg C, Aukrust P, Molberg Ø, Belperio JA, Hoffmann-Vold AM. Tennøe AH, et al. Among authors: midtvedt o. Sci Rep. 2022 Mar 18;12(1):4661. doi: 10.1038/s41598-022-08815-8. Sci Rep. 2022. PMID: 35304587 Free PMC article.
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.
Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, Truchetet ME, Giollo A, Balbir-Gurman A, Martin M, Denton CP, Gabrielli A, Del Galdo F, Vonk MC, Fretheim H, Bitter H, Midtvedt Ø, Andreassen A, Høie S, Tanaka Y, Riemekasten G, Müller-Ladner U, Matucci-Cerinic M, Castellví I, Siegert E, Hachulla E, Molberg Ø, Distler O, Hoffmann-Vold AM; EUSTAR Collaborators. Bjørkekjær HJ, et al. Among authors: midtvedt o. Rheumatology (Oxford). 2025 Jun 1;64(6):3643-3656. doi: 10.1093/rheumatology/keaf053. Rheumatology (Oxford). 2025. PMID: 39878955 Free PMC article.
58 results